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Abstract. Conformations of valinomycin and its complexes with Perchlorate and thiocyanate 
salts of barium, in a medium polar solvent acetonitrile, were studied using nuclear magnetic 
resonance spectroscopic techniques. Valinomycin was shown to have a bracelet conformation
in acetonitrile. With the doubly charged barium ion, the molecule, at lower concentrations, 
predominantly formed a 1:1 complex. At higher concentrations, however, apart from the 1:1, 
peptide as well as ion sandwich complexes were formed in addition to a ‘final complex’. Unlike 
the standard 1:1 potassium complex, where the ion was centrally located in a bracelet 
conformation, the 1:1 barium complex contained the barium ion at the periphery. The ‘final 
complex’ appeared to be an open conformation with no internal hydrogen bonds and has two
bound barium ions. This complex was probably made of average of many closely related
conformations that were exchanging very fast (on nuclear magnetic resonance time scale) 
among them. The conformation of the ‘final complex’ resembled the conformation obtained in
the solid state. Unlike the Perchlorate anion, the thiocyanate anion seemed to have a definite
role in stabilising the various complexes. While the conformation of the 1:1 complex indicated
a mechanism of ion capture at the membrane interface, the sandwich complexes might explain
the transport process by a relay mechanism.
 
Keywords. NMR study; conformation; ionophores; valinomycin-barium complex; trans-
membrane ion-transport. 
 
Introduction 
 
Valinomycin is a cyclic dodecadepsipeptide, which has been well studied as a model
system for understanding biological transport across membranes in higher organisms
(Ovchinnikov et al.,1974; Stark, 1978; Ovchinnikov, 1979; Lauger, 1980; Lauger, et al.,
1981). Two most important characteristics of the molecule that have come out of these
studies are (i) its selective transport of K+ over Na+ (by a factor of over 104), both in
natural (Pressman, 1965) as well as synthetic (Mueller and Rudin, 1967) membranes,
which explains its antibiotic activity and (ii) its solvent dependent conformations (Patel
and Tonelli, 1973; Ovchinnikov, et al., 1974) that help provide explanations for the
mechanism of transport. While it is true that some of the conformations of valinomycin 
have been characterised to a great extent (Duax et al., 1972; Patel and Tonelli, 1973;
Ovchinnikov and Ivanov, 1974; Ovchinnikov et al., 1974; Karle, 1975; Neupert-Laves
and Dobler, 1975; Smith et al., 1975; Bystrov et al., 1977), all the conformational
 
 
Abbreviations used: NMR, Nuclear magnetic resonance; CD, circular dichroism; ppm, parts per million; 
TMS, tetramethyl silane; Val, valine; Hylv, hydroxyisovaleric acid; Lac, lactic.
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possibilities for the molecule have not been explored efficiently. Providing an exact
mechanism of transport by the molecule depends on knowing the various conforma-
tional rearrangements the molecule has to undergo within the membrane, and this can 
possibly be achieved by studying the conformation of the molecule under a variety of 
solution and salt conditions. To this end, we have characterised the barium complexes
of valinomycin in acetonitrile solvent. Ba2+ (1·38 A) has almost the same ionic radius as 
K+ (1·33 A) but has a double charge and therefore the effect of increased charge on the 
complex conformation of the molecule can be well studied. Some of the results
obtained using circular dichroism (CD), X-ray and nuclear magnetic resonance (NMR)
techniques have already been reported (Devarajan et al., 1980; Devarajan and
Easwaran, 1981; Devarajan et al., 1983). In this paper, we report a detailed NMR study
of barium complexation with valinomycin. 
 
 
Materials and methods
 
Valinomycin was obtained from Sigma Chemical Company, St. Louis, Missouri, USA 
and was used as such. Only Perchlorate and thiocyanate salts were used for
complexation studies as they showed low cation-anion interactions. The perchlorate
salt was prepared by neutralising barium hydroxide with perchloric acid and then
drying. The thiocyanate salt was a gift from Shemyakin Institute of Biorganic
Chemistry, Moscow, USSR. The salts were dried in vacuum over phosphorous
pentoxide for several days before use.
All the deuterated solvents were purchased from Stohler Isotope Company,
Massachusetts, USA and were used as such. The free radical 2,2,6,6 tetramethyl
piperiden-1-oxyl was a gift from Prof. K. D. Kopple. The NMR spectra were recorded
using Bruker WH 270 FT-NMR spectrometer of the Sophisticated Instrumentation
Facility, Indian Institute of Science, Bangalore, under controlled FT mode, at 270 MHz 
for 1H and 67·89 MHz for 13C. Five mm and 10 mm diameter NMR tubes from 
Wilmad Glass Company were used for 1H and 13 C respectively. The13 CNMR spectra
were recorded with broad band decoupling of the coupled protons. For ally experiments, 
deuterium signals from solvents were used for locking the magnetic field of the 
spectrometer. The chemical shifts were measured in parts per million (ppm) with
respect to internally added tetramethyl silane (TMS). The experiments were performed
in CD3CN unless otherwise stated. The stoichiometrics mentioned in this paper
correspond to valinomycin: metal salt in that order only.
 
 
Results and discussion
 
Proton NMR studies
 
Conformation of valinomycin in acetonitrile: The conformation of valinomycin was
determined in deuterated acetonitrile (CD3CN) a solvent used through out this study as
valinomycin assumes solvent dependent conformations.
Table 1 lists the Cα proton chemical shifts and coupling constants of valinomycin in
various conformations. Apart from the similarity of Cα proton chemical shifts, the 
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Table 1. A comparison of chemical shifts and coupling constants for valinomycin in various
states. 
 
 
coupling constants are also very close for valinomycin in CD3CN and A conformation. 
Also, a free radical (2,2,6,6, tetramethyl piperiden-1-oxyl) which is capable of
broadening any exposed amide proton (Kopple et al., 1978) on addition to valinomycin
and its K+ complex in CD3CN under identical valinomycin concentration conditions,
does not cause any broadening in both the systems (figure 1). This observation 
indicated that all the valinomycin amide protons were hydrogen bonded in CD3CN 
just as in its K+ complex. Figure 2 shows the effect of changing the solvent from
nonpolar CDC13 (chloroform) to CD3CN, on the carbonyl carbons chemical shifts.
The amide carbonyl carbons [L-lactic (Lac) and D-hydroxyisovaleric acid (HyIv)] that
are involved in hydrogen bonding shift only slightly, indicating that the hydrogen
bonding scheme is same in both the solvents. The shifts in the ester carbonyl carbons
 
 
Figure 1. Effect of free radical addition to valinomycin and its Κ+ complex both in CD3CN.
Valinomycin concentration is 8·9 mM. A. Before addition. B. After addition.
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Figure 2. Solvent titration for the assignment of carbonyl signals of free valinomycin in
CD3 CN; X axis: volume per cent of CDC13 or CD3CN; Υ axis: (ppm) with reference to TMS.
 
 
[L- and D-valine (Val)] seen in figure 2, indicated a changed orientation for these
groups. Thus valinomycin assumes A conformation in CD3CN (CH3CN) with all its
hydrogen bonds intact.
 
Studies on valinomycin-barium complexes: It has been known that chemical shift
positions of the Cα protons are sensitive to the conformation of the molecule, in
particular to the change in orientation of the adjacent carbonyls (Grell and Funck, 
1973a). The carbonyls can change their orientation in metal complexation studies to,
either ligand effectively with the cation, or accommodate the resultant conformational
changes by adjusting the hydrogen bond scheme. Therefore, conformational charac-
terisation of the various complexes can be achieved, by following the chemical shift
changes at the various Cα protons. The shifts in the amide protons give an idea about
hydrogen-bond scheme.
 
Studies on valinomycin-barium Perchlorate complexes
 
At lower valinomycin concentrations: Figure 3 shows the chemical shift changes for the
NH and CαH signals of valinomycin (0·37 mM) with barium Perchlorate addition. A
plateau at 1:1 indicated stabilisation of the 1:1 complex. Three points emerged from a 
comparison of these chemical shifts with those corresponding to K+ addition
(Ovchinnikov and Ivanov, 1974). (1) The amide protons (L- and D-Val NH’s) showed a
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large low-field shift with the K+ complex formation, but have only a small high-field 
shift with the Ba2+ complex formation. (2) While the L-Val CαH showed a considerable 
high-field shift (0·28 ppm) with the K+ complex formation, it almost did not produce
shift with the Ba2+ complex formation. (3) The shift in D-Val, L-Lac and D-Hylv 
CαH’s was in the same direction in both the complexes. However, the magnitude of 
shifts for the barium complex was smaller. 
The larger low-field shift of the amide protons in the K+ complex could be attributed 
to the electron withdrawing effect of the nearby K+ ion. The doubly charged barium 
ion (which could have caused a still larger low-field shift, if it were to occupy the K+ 
position) could be only at the periphery of the bracelet. The absence of a change in the 
chemical shift position of the L-Val CαH indicated that the binding was not from the L- 
Val side definitely, and could be from the D-Val side. 
The small high-field shift of the amide protons indicated some weakening of 
hydrogen bonds. This result suggested that the amide (L-Lac and D-Hylv) were turning 
away from an hydrogen bonded position, to co-ordinate with the barium ion. The large 
high-field shifts in L-Lac and D-Hylv CαH’s seemed to confirm such a possibility. The 
shift in the D-Val CαH though high-field as in the K+ complex, was smaller. This study 
indicated that this ester carbonyl, though turned inward as in the K+ complex, did not 
have to change its orientation markedly. 
All these inferences indicated a 1:1 barium complex in which the barium ion was
positioned at the periphery of the bracelet, on the D-Val side, complexing with D-Val,
L-Lac and D-Hylv carbonyl oxygens (Devarajan and Easwaran, 1981). The ion
possibly still retained part of its hydration shell. Preference for the D-Val side for 
complexation could be attributed to the presence of lesser number of side chains and 
therefore lesser steric hindrance when compared with the L-Val side. The failure to 
form ‘valinomycin-K+’ like complex was probably due to the larger solution sheath 
that surrounds Ba2+. 
 
At higher valinomycin concentrations: At concentrations higher than 5 mM, CD studies
showed that valinomycin formed, apart from 1:1, 2:1 (peptide sandwich) and 1:2 (ion
sandwich) complexes and a ‘final complex’ (Devarajan and Easwaran, 1981). Figure 4
shows the titration graph obtained by the addition of barium Perchlorate to
 
Figure 3. Barium perchlorate addition to vali-
nomycin at 0.37 mM concentration. The stabilis-
ation of the signals at 1:1 is clearly seen 
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Figure 4. Chemical shift changes at a higher valinomycin concenration, on the addition of 
barium Perchlorate salt. [VM] ~ 21 mM. 
 
 
Table 2. Changes in chemical shift values, with barium Perchlorate 
addition, for various protons upto 1:1, and beyond 1:1 until the end 
of titration. Valinomycin concentration ~ 21 mM (ppm units). 
 
 
 
valinomycin at ~ 21 mM concentration. A sharp break at 1:1 and a semblance of 
plateau region at a large excess addition of the barium salt only were seen. The various
complexes that are expected to form (2:1 and 1:1 in the beginning stages, and 1:2 and
the ‘final complex’ in the later stages) seemed to be exchanging at a rate faster than
NMR time scale and the chemical shift positions therefore represented an average of
the various conformations. 
Table 2 lists the changes in chemical shift values for the various protons upto 1:1 and
beyond 1:1 until the end of the titration. The changes observed up to 1:1 in this
titration were less (though similar), when compared with that carried out at 0·37 mM,
indicating formation of complexes other than the 1:1 that have opposing influences on
the chemical shift changes. The CD studies have indicated that 2:1 complex forms at
this stage of titration and has CD contributions opposite to that of 1:1. 
Figure 5 represents the N H and the CαH region for a few of the titration points, in the
beginning of the experiment. Except L-Val CαH all other lines showed considerable
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Figure 5. Broadening of the amide and the CαH signals except the L-Val CαH, in the initial
stages of the Perchlorate salt addition. The data points correspond to the titration represented
in figure 4. The ratios for the data points are (A) 1:0, (B) 1:0·10 (C) 1:0·29 and (D) 1:0·58.
 
 
broadening. The absence of any shift (as indicated earlier) or broadening for the L-Val 
CαH, when the 2:1 complex also formed, indicated that the L-Val side was not involved 
in metal binding in this complex also probably due to steric reasons. The ion was held 
by six D-Val carbonyl oxygens (Devarajan and Easwaran, 1981). 
Thus, by following subtle changes in NMR parameters at a higher valinomycin 
concentration (~ 21 mM), it was possible to confirm the formation of the 2:1 complex.
Similarly the formation of 1:2 (ion sandwich) is confirmed by following chemical shift
changes at a lower temperature (– 40°C), Figure 6 shows that all the lines except that of
the L-Val CαH split into two lines, at – 40°C, one representing the free and the other,
the complex. The lines nearly remain unchanged in their chemical shift positions till
1:1. The complex lines grew, while the free lines decrease in intensity (not shown). The
most important difference to be noted with respect to the room temperature titration 
(figure 4), was the low-field shift of the NH signals beyond 1:1 at low temperature. This 
observation indicates stabilization of a complex that retained hydrogen bonds—
probably the formation of the 1:2 ion sandwich complex, having two barium ions, one 
on either side of a valinomycin bracelet, held by three ester carbonyls. The other side of 
the ion would be exposed to interaction with the anions and the solvent molecules.
Determinations of conformations based on NMR parameters was not easy, when 
these parameters represent an average of many conformations that were exchanging 
very rapidly among themselves, with no single predominant conformation. Because of 
this reason, exact conformational characterisation of the various intermediate com- 
plexes was not possible. However, at the very end of the titration (as in figure 4), there 
was an induction of a plateau region, possibly representing the predominant formation
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Figure 6. A low temperature (—40°C) titration with barium Perchlorate salt. [VM]
~ 12 mM. Splitting of all lines except that of L-Val CαH can be seen. Free lines disappear at
1:1. 
 
 
of the ‘final complex’ as reported previously (Devarajan et al., 1980; Devarajan and
Easwaran, 1981). Conformational characterisation of this complex will be reported in 
the latter part of this paper. 
 
Studies on valinomycin-barium thiocyanate complexes
 
At lower valinomycin concentration: With barium thiocyanate salt, valinomycin at low 
concentrations (0.37 mM) formed a 1:1 complex involving the sterically less hindered 
D-Val side, as with the Perchlorate salt. However, unlike in the Perchlorate case, the 
complex was not stable even at this low valinomycin concentration as indicated by the 
lack of plateau region for the L- and D-Val CαH signals beyond 1:1.
 
At higher valinomycin concentration: At a higher valinomycin concentration
(~3 mM), even the L-Val CαH begins to show changes in the chemical shift position,
just from the beginning of barium thiocyanate addition (figure 7). This was in contrast 
to the titration corresponding to barium Perchlorate addition (figure 4). Also, a plateau 
region beyond 1:2, which was not obtained unless a large excess of the Perchlorate salt 
was added, was easily discerned just beyond 1:2 in the thiocyanate case. While the 
changes in the L-Val CαH from the beginning of the thiocyanate salt addition indicated 
the formation of a L-Val side involved complex, the faster approach of the plateau 
region beyond 1:2 indicates a facilitated formation of the ‘final complex’ in the
presence of the thiocyanate anion.
It can be seen below that the L-Val side involved valinomycin barium thiocyanate
complex, that forms in the beginning of the thiocyanate salt addition, has to be a 1:1 
complex and definitely not a 2:1 complex. This complex was not formed upon the
addition of the Perchlorate salt and therefore must involve the linear thiocyanate
anions for its formation. The formation of the 2:1 complex does not involve anions or
<< 
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Figure 7. Chemical shift changes at a valinomycin concentration of ~ 3 mM, with barium
thiocyanate salt addition, at L- and D-Val CαH region. 
 
solvent molecules, while the formation of the 1:1 complex is definitely aided by anions
and solvent molecules. Because of the involvement of the sterically crowded L-Val side
for the complex formation, the superior liganding capacity of the linear anion
(thiocyanate) might be needed to stabilise this complex.
 
Carbon-13 studies 
 
Because of the lower natural abundance (1·1 %) and the lesser inherent sensitivity of
carbon-13 with respect to proton (Deslauriers and Smith, 1980), there is always a
necessity to use a larger concentration of the sample to obtain a good 13C spectrum.
Therefore, the interesting observations made in proton NMR at lower valinomycin
concentrations (like at ~ 0.4 mM), could not be confirmed by carbon-13 studies. The
low field shift of carbonyl carbons in metal binding (Bystrov et al., 1977), was exploited
by following the chemical shift changes of these carbons to supplement the
conformational characterisations of the complexes using proton NMR studies.
 
On valinomycin-barium Perchlorate complexes: Figure 8 represents the chemical shift 
changes at the carbonyl carbon region of valinomycin, upon the addition of barium 
perchlorate. The titration graph clearly showed the break at 1:1, and stabilisation at 
1:2. The high-field shift in the L-Val13   signal, in the initial stages of salt addition, 
 
 
confirmed the non-participation of L-Val side in metal binding probably due to steric
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reasons. The low-field shifting of D-Val L-Lac and D-HyIv13  s confirmed the
 
 
participation of all these carbonyls from the D-Val side in metal binding and provided a 
possible explanation for the weakening of hydrogen bonding scheme. When a large
excess addition of the Perchlorate was added (1:13, not shown in figure 8, i.e. the ‘final
complex’ is expected to form), L-Lac and D-Hylv 13  s remained at low field
 
 
(Δ   = 1·29 and 1·37 ppm respectively) indicating disengagement of the D-Val 13 
 
 
from metal binding. Therefore, the ‘final complex’ seemed to involve only amide 
carbonyls for metal binding unlike all other valinomycin-metal complexes so far
reported in the literature (Ovchinnikov et al., 1974; Bystrov et al., 1977).
 
On valinomycin-barium thiocyanate complexes: Figure 9 represents the chemical shift 
changes at the carbonyl carbon region of valinomycin, on the addition of barium
thiocyanate salt The break shown at 1:1 by the L-Val 13   and the stabilisation of the 
 
 
chemical shift changes of all the signals just beyond 1:2 confirmed the formation of 1:1
and 1:2 respectively.
Figure 8. A 13C NMR titration, representing
chemical shift changes at the carbonyl region of
valinomycin, with the addition of barium per-
chlorate salt 
Figure 9. A 13C NMR titration, representing
chemical shift changes at the carbonyl region of
valinomycin, with the addition of barium
thiocyanate salt.
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The proton studies indicated that an L-Val side involved 1:1 complex was also
formed in the presence of the thiocyanate anion. However, the L-Val 13   did not shift
 
 low field even to a limited extent contrary to expectations. It could be seen from
literature (Bystrov et al., 1977) that when there was opening of the bracelet
conformation, the L- and D-Val 13C’s shifted high-field. Therefore, it is possible that in
 
the initial stages of the thiocyanate salt addition, the low-field shift of the L-Val 13  
 
 
expected with the formation of the L-Val side involved 1:1 complex was compensated 
with the high-field shift of the above signal caused by the formation of a small amount
of the ‘final complex’ with its open conformation. It is interesting to note at this point
that in the corresponding 13C titration performed with the Perchlorate, the L-Val 13 
 
 
moves high-field from the beginning of the salt addition. The chemical shift changes in
the carbonyl region beyond 1:1 in the present titration (figure 9) are similar to those in
the Perchlorate case (figure 8), confirming the formation of a ‘final complex’ with 1:2
stoichiometry.
 
 
Conformation of the final complex
 
From solution studies: In our earlier paper dealing with CD studies (Devarajan and 
Easwaran, 1981), the complex that was formed near the end of the barium salt addition 
was termed as the ‘final complex’. From 13CNMR studies (see above), it was clear that 
this complex had 1:2 stoichiometry and the amide carbonyls were involved in metal 
binding. The inference from the CD studies that this complex may have an open 
conformation was confirmed by the shift of NH to highfield near the end of barium salt 
addition to valinomycin (figure 4) and also from a free radical experiment as shown in 
figure 10. This experiment was conducted at identical concentrations for both
valinomycin and the free radical as in the case of uncomplexed valinomycin and its K+ 
complex (see figure 1). While there was no broadening of the amide protons in the case
of the both free valinomycin and its K+ complex (figure 1), noticeable broadening for
these protons was observed, in the case of the 'final complex’ (figure 10).
The coupling constants that are measured for the ‘final complex’ and the probable ø
values corresponding to these constants are listed in table 3. Model building studies 
clearly ruled out conformations with ø values +40° and +80° for L-Val ( –40° and
–80° for D-Val), but allowed the other two conformational angles. It can be seen from
energy maps corresponding to the various residues present in the valinomycin molecule 
(Ovchinnikov and Ivanov, 1974; figure 11) that, although at one Ψ value or the other, 
each of the four ø values mentioned above become allowed, it is only around ø = – 80° 
for L-Val (+ 80° for D-Val), the global minimum energy is found. Also, only at this
region of the energy map, large changes in the conformational angles are allowed with 
only a small increase in energy. For example, the ø values can be changed by ± 50° with
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Figure 10.  Effect of free radical addition on the ‘finale complexes’ of the barium salts, with
valinomycin. Valinomycin concentration is ~ 8·9 mM in both the systems. A. Before addition. 
B. After addition. 
 
 
Table 3. Coupling constants measured and the cor-
responding dihedral angles for the ‘finale complex’.
 
 
only 1 or 2 kcal increase in energy. Since the ‘final complex’ has an open conformation, it 
may have a lot of flexibility and ø values — 80° for L-Val and + 80° for D-Val seem to be 
ideal for accommodating this flexibility. 
 
Comparison with the conformation in the solid state: In the single crystal studies of 
valinomycin barium Perchlorate complex (Devarajan et al., 1980), it has been found 
that valinomycin molecule was in an open conformation (with no hydrogen bonds) and 
held two cations by its amide carbonyls (figure 12). Thus in all major aspects, the 
conformation observed in the solid state was very similar to that in the ‘final complex’. 
However, while the NMR studies on the ‘final complex’ have constantly shown a 
conformer that is C3 symmetric in NMR time scale, the solid state conformer is non C3 
symmetric. Possibly if there are a good number of near equi-energy conformational 
states in solution that are non C3 symmetric in nature, a fast exchange (in NMR time 
scale), among these conformers may result in the C3 symmetry observed in NMR. 
 
Exchange among near equi-energy states
 
Figure 11 shows the conformational energy maps of the four individual residues L-Val, 
D-HyIv, DVal and L-Lac. The conformational angles observed in the solid state and 
their mean values are shown in figure 4. Table 4 lists all the mean values and the 
maximum deviations of the observed values from these mean values on either side, for 
, 
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Figure 11. Conformational energy maps for the various residues present in valinomycin
(taken from Ovchinnikov and Ivanov, 1974). 
 
all the four individual residues. The deviations from the mean values were less than 30°
except for the ø value of one L-Val residue which deviated by about 44°. It can be seen
from figure 11 that the ø value assumed by this residue (–121°) falls on an energy
contour that shows the same energy at the ø value (– 77°) that is mean for all the L-Val
residues. Therefore there will not be any increase in conformational energy despite such 
a large deviation from the mean. 
It can be seen from figure 11 that, for a residue, the conformational changes on either 
side of the mean (± 30°) can be achieved by 3 or 4 kcals gain or loss of energy. In the 
molecule, conformational changes can occur such that the gain in energy at one residue 
can compensate for the loss at another residue. Apart from such equi-energy states, 
there can be many other conformational states which differ just by 1 or 2 kcal change in 
energy. Assuming that the mean conformational angles represented in table 4 
correspond to an average conformation in solution, all the conformational angles that
are observed for a residue (Devarajan, 1982) on either side of this calculated mean value
can be achieved with a minimum change in the conformational energy. As the energy
separation among these various conformational states is not high, the populations that
occupy each individual conformational state may be very close, and the exchange
among these also may be fast, leaving the molecule to achieve C3 symmetry on an
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Figure 12. ‘Top’ view of the valinomycin molecule in its (A) barium Perchlorate complex
(Devarajan el al., 1983) and (B) Potassium iodide complex (Neupert-Laves and Dobler, 1975).
C and D. Represent the corresponding ‘side’ views, with the side chain atoms and carbonyl
oxygens omitted for clarity. The residue numbering is indicated in (A).
 
 
 
Table 4. Mean values and the deviations on either side from the mean values for the various 
conformational angles (degrees) observed in the two valinomycin-barium structures solved in
the solid state (Max = maximum value, Min = minimum value; Devarajan, 1982). 
 
 
average, from many near equi-energy non C3 symmetric conformational states. Thus
the ‘final complex’ obtained in solution on an average may resemble the conformation 
observed in the solid state. 
 
 
Conclusions 
 
It is known that barium ion interferes with physiological functions involving specific
binding of K+ ion, because of its similar size (A rmstrong and Taylor, 1980). Due to its
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higher charge density and the resultant larger solvation sheath, the double charged
barium ion shows a tendency to retain part of its solvation sheath in almost all the
complex structures (Johnson et al., 1970; Metz et al., 1971; McClelland, 1974; Raston 
and White, 1976; Hughes et al., 1978). This tendency was found even in situations where
K+ did not retain any solvent molecule under identical conditions (Metz et al., 1971).
This could be one of the reasons why the ‘final complex’ and the two barium complexes
solved in the solid state have a flat conformation probably to allow the alkaline earth 
metal to be accessible to anions and solvent molecules from both sides. 
The ‘final complex’ of valinomycin-barium system has been unambiguously
characterized as an open conformation. This can serve as a model for valinomycin
conformation in polar solvents. We have also confirmed the formation of both peptide
as well as ion sandwich complexes apart from two peripherally-ion-bound-1:1 
complexes. While the open conformation may not serve any useful role to explain the 
transport process, the peripherally-ion-bound 1:1 complexes definitely aid in explain-
ing the complexation mechanism at the membrane interface and the sandwich
complexes help in understanding a modified carrier system involving more than one
carrier (a relay mechanism) and indicate the possibility of ion-transport by a channel
mechanism involving a column of stacked carriers.
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